Vanda Pharmaceuticals Inc

General

Total Cases41

Active Cases7

Patents117

CourtsD. Delaware D. New Jersey S.D. Florida

TypeOperating Company

Elite Ratings

--

vandapharma.com

vanda-pharmaceuticals

vanda-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L3

A

PTAB

L1

C

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/08/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	NOTICE OF SERVICE of (1) Vanda Pharmaceutical Inc.'s Rule 26(a)(1) Initial Disclosures and (2) Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 10/08/2024)
10/08/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 10/08/2024)
10/07/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	NOTICE OF SERVICE of (1) Defendants Apotex Inc. and Apotex Corp.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendants Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Apotex Corp., Apotex Inc..(Ekiner, Kaan) (Entered: 10/07/2024)
10/03/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	STIPULATION TO EXTEND TIME the deadline for the parties to submit a proposed protective order to October 17, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 10/03/2024)
10/03/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	SO ORDERED, re (126 in 1:23-cv-00152-JLH, 118 in 1:23-cv-00153-JLH) Stipulation and Order to Extend Time for the parties to submit a proposed protective order to October 17, 2024. Ordered by Judge Jennifer L. Hall on 10/3/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 10/03/2024)
10/01/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	SO ORDERED, re (125 in 1:23-cv-00152-JLH, 117 in 1:23-cv-00153-JLH) Stipulation and Order to Extend the deadline for the parties to serve their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Default Standard for Discovery to October 7, 2024. Ordered by Judge Jennifer L. Hall on 10/1/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 10/01/2024) SO ORDERED, re (125 in 1:23-cv-00152-JLH, 117 in 1:23-cv-00153-JLH) Stipulation and Order to Extend the deadline for the parties to serve their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Default Standard for Discovery to October 7, 2024. Ordered by Judge Jennifer L. Hall on 10/1/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 10/01/2024)
09/30/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	STIPULATION TO EXTEND TIME the deadline for the parties to serve their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Default Standard for Discovery to October 7, 2024 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 09/30/2024)
09/23/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	SCHEDULING ORDER: Case Nos. 23-152-JLH and 23-153-JLH are coordinated for pretrial purposes ONLY. Joinder of Parties due by 11/21/2024. Amended Pleadings due by 11/21/2024. Fact Discovery completed by 5/9/2025. Expert Discovery due by 10/3/2025. Joint Claim Construction Chart due by 10/21/2024. Joint Claim Construction Brief due by 1/6/2025. Amended Joint Claim Construction Chart due no earlier than 1/13/2025. A Markman Hearing is set for 3/6/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Status Report due 7 days after Markman decision. Dispositive and Daubert Motions due by 10/24/2025. Answering Briefs due by 11/21/2025. Reply Briefs due by 12/5/2025. A Hearing on any pending Dispositive and Daubert motions is set for 1/16/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Proposed Pretrial Order due by 3/13/2026. A Pretrial Conference is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. The first 4-day Jury Trial is set for 4/20/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall. (See Order for details). Signed by Judge Jennifer L. Hall on 9/23/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 09/23/2024) SCHEDULING ORDER: Case Nos. 23-152-JLH and 23-153-JLH are coordinated for pretrial purposes ONLY. Joinder of Parties due by 11/21/2024. Amended Pleadings due by 11/21/2024. Fact Discovery completed by 5/9/2025. Expert Discovery due by 10/3/2025. Joint Claim Construction Chart due by 10/21/2024. Joint Claim Construction Brief due by 1/6/2025. Amended Joint Claim Construction Chart due no earlier than 1/13/2025. A Markman Hearing is set for 3/6/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Status Report due 7 days after Markman decision. Dispositive and Daubert Motions due by 10/24/2025. Answering Briefs due by 11/21/2025. Reply Briefs due by 12/5/2025. A Hearing on any pending Dispositive and Daubert motions is set for 1/16/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Joint Proposed Pretrial Order due by 3/13/2026. A Pretrial Conference is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. The first 4-day Jury Trial is set for 4/20/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall. (See Order for details). Signed by Judge Jennifer L. Hall on 9/23/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 09/23/2024)
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)
09/17/24	Vanda Pharmaceuticals Inc v. Inventia Healthcare Ltd 1:15-CV-00362 ( D. DE )	Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024)